Market map · Europe
AI drug discovery market map: Europe
43 AI drug discovery startups based in Europe that have raised money in rounds we track, placed in 3 segments by what each says it does. Together they have raised $3.9B; the biggest segment is AI discovery platforms.
Isomorphic Labs
BenevolentAI
Genomics
Causaly
Latent Labs
Algorithmiq
Orakl Oncology
Eagle Genomics
CoSyne Therapeutics
VRG Therapeutics
Multiomic Health
Cytomos
Axiom Therapeutics
RECEPTOR.AI
Arctoris
Imperagen
DaltonTx
SilicoLife
DeepLife
WhiteLab Genomics
Semarion
Ignota Labs
Pheiron
Iktos
+10 more
Funding by segment
- AI discovery platforms$3.8B34
- Small molecules$33M6
- Protein design$120M3
Where they are based
- United Kingdom25$3.8B
- France5$60M
- Netherlands2$3.8M
- Switzerland2$1.6M
- Finland1$37M
- Hungary1$21M
- Portugal1$10M
- Germany1$4.2M
- Lithuania1$1.4M
- Sweden1$444K
United Kingdom
France
Netherlands
Switzerland
Finland
Hungary
Portugal
Germany
Lithuania
SwedenFounded
2 without a founding year on record.
Total raised
- Under $1M5
- $1M to $10M14
- $10M to $50M19
- $50M to $250M4
- $250M to $1B0
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
41 of 43 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom25
- France5
- Netherlands2
- Switzerland2
- Finland1
- Hungary1
- Portugal1
- Germany1
- Lithuania1
- Sweden1
- Poland1
- Latvia1
Poland
LatviaStartups by country, 13 countries in all.
Segment by segment
AI discovery platforms
34 startups · $3.8B raised
- Isomorphic LabsIsomorphic Labs is a London-based artificial intelligence company focused on transforming the drug discovery process.United Kingdom$3.1B
- BenevolentAIBenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.United Kingdom$205M
- GenomicsGenomics Ltd, founded in 2014 in Oxford, UK, is a global techbio and precision medicine company.United Kingdom$93M
- CausalyCausaly is a London-based artificial intelligence company founded in 2018, specializing in a biomedical research platform that accUnited Kingdom$60M
- Latent LabsLatent Labs is an artificial intelligence research laboratory and biotechnology company founded in 2023 and based in London, with United Kingdom$40M
- AlgorithmiqAlgorithmiq is a quantum software company based in Helsinki, founded in 2020.Finland$37M
- Orakl OncologyOrakl Oncology is a French techbio startup founded in 2023 as a spin-off from the Gustave Roussy Institute, a leading cancer research center.France$35M
- Eagle GenomicsEagle Genomics is a TechBio company based at the Wellcome Genome Campus in Cambridge, UK.United Kingdom$33M
Small molecules
6 startups · $33M raised
- ABAquapharm BiodiscoveryAquapharm Biodiscovery is a drug discovery company developing products based on the chemical diversity of marine microorganisms.United Kingdom$16M
PharmEnable TherapeuticsPharmEnable Therapeutics is a private drug discovery biotechnology company based in Cambridge, UK, founded in 2016 as a spin-out fUnited Kingdom$7.5M
KuanoKuano is a UK-based biotechnology company founded in 2020, specializing in drug discovery.United Kingdom$4.8M
HotHouse TherapeuticsHotHouse Therapeutics is a biotechnology and synthetic biology company based in Norwich, United Kingdom.United Kingdom$2.5M
Molecule.onemolecule.one is an AI-driven biotechnology company focused on autonomous chemical synthesis and drug discovery.Poland$1.0M
MolPortMolport is a global B2B chemical marketplace founded in 2006 in Latvia.Latvia$766K
Protein design
3 startups · $120M raised
NucleraNuclera is a biotechnology company focused on making proteins more accessible to enhance drug discovery, proteomics, and life scieUnited Kingdom$95M
AntiverseAntiverse is a techbio company based in Cardiff, UK, with an office in Boston, MA.United Kingdom$14M
ALLOXALLOX is a techbio startup founded in 2023, emerging from Barcelona's Centre for Genomic Regulation.Spain$11M
SpainHow this map is made. Every startup here has raised money in rounds we track, and is based in Europe. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in AI drug discovery, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.
More market maps
All mapsWho backs AI drug discovery?
Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.